Synergy vs. Optimization
Achieving drug synergy and optimizing combination therapy are two very different outcomes. During the course of combination therapy, synergy can convert to antagonism in the same patient, and vice versa. Furthermore, truly optimizing combination therapy is based on finding and maintaining the best possible drug interactions in a dynamic fashion.
The foundation of Project NDX is to make game-changing nanodiamond therapies accessible.
What's a Nanodiamond? The NDX project started with a vision that cancer treatment could be dramatically enhanced with a tiny carbon nanodiamond particle that is thousands of times smaller than the width of a human hair (only 5 nanometers in diameter!).
Nanodiamonds are byproducts of mining and refining, meaning they are already created on a daily basis, and they are inexpensive! This makes them an ideal platform for sustainable nanomedicine.
Using simple cleaning procedures, they can be made safe for biomedical applications.
Their surface properties are unique and remarkable, and have redefined drug delivery and imaging.
Our discoveries have been highlighted in leading peer-reviewed journals.